Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$191B
sum of reported positions
Reported positions
222
Changes vs prior quarter
152
9 new · 9 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 188 measured positions in 8 quarters, the typical new or larger position finished −4.1 pts against the S&P 500 and 37% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 55.8M | $8.15B | 4.3% | |
| 77M | $7.1B | 3.7% | |
| 35.1M | $6.66B | 3.5% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $182B | $191B |
| Positions | 222 | 222 |
| Biggest line | — | Johnson Controls 4% |
| 50M |
| $5.17B |
| 2.7% |
| 12.8M | $4.79B | 2.5% |
| 25.5M | $4.55B | 2.4% |
| 10.9M | $4.35B | 2.3% |
| 12M | $4.23B | 2.2% |
| 48.4M | $4.1B | 2.1% |
| 54.8M | $4.1B | 2.1% |
| 16.7M | $3.98B | 2.1% |
| 10.7M | $3.81B | 2.0% |
| 9.07M | $3.77B | 2.0% |
| 6.49M | $3.66B | 1.9% |
| 72.8M | $3.53B | 1.9% |
| 17M | $3.42B | 1.8% |
| 12.2M | $3.36B | 1.8% |
| 4.87M | $3.04B | 1.6% |
| 23.7M | $2.99B | 1.6% |
| 37M | $2.93B | 1.5% |
| 8.59M | $2.85B | 1.5% |
| 116M | $2.85B | 1.5% |
| 9.39M | $2.75B | 1.4% |
| 44M | $2.69B | 1.4% |
| 61.2M | $2.61B | 1.4% |
TransUnion (TRU)
16.2M → 24.2M shares (+50%)
Thermo Fisher Scientific (TMO)
26K → 3.05M shares (+11767%)
Haleon (HLN)
147M → 150M shares (+2%)
Lpl Financial (LPLA)
4.15M → 4.58M shares (+10%)
Baxter International (BAX)
57.3M → 58.4M shares (+2%)
T-Mobile (TMUS)
6.16M → 6.34M shares (+3%)
Ralliant Corp (RAL)
13.7M → 14M shares (+2%)
Novo Nordisk (NVO)
19.3M → 20.4M shares (+6%)
Neurocrine Biosciences (NBIX)
5.46M → 5.58M shares (+2%)
HP Inc. (HPQ)
41.6M → 42.6M shares (+3%)
BioMarin Pharmaceutical (BMRN)
14.6M → 14.8M shares (+2%)
First Citizens Bancshares Inc (FCNCA)
393K → 404K shares (+3%)
Molson Coors Beverage (TAP)
18.5M → 19.1M shares (+3%)
Taiwan Semiconductor Manufacturing (TSM)
108K → 1.44M shares (+1237%)
Adobe (ADBE)
2.5M → 3.11M shares (+25%)
Medtronic (MDT)
7.69M → 7.88M shares (+2%)
Gaming and Leisure Properties (GLPI)
13.5M → 13.8M shares (+2%)
Alnylam Pharmaceuticals (ALNY)
1.93M → 1.96M shares (+1%)
Fox Corporation (Class A) (FOXA)
10.9M → 11.2M shares (+3%)
Cognizant (CTSH)
14.3M → 14.5M shares (+2%)
Fox Corp.
7.18M → 7.27M shares (+1%)
News Corp (Class A) (NWSA)
12.3M → 12.5M shares (+2%)
Hdfc Bank (HDB)
5.69M → 6.68M shares (+17%)
Danaher Corporation (DHR)
16K → 257K shares (+1463%)
Liberty Global (LBTYA)
2.14M → 2.44M shares (+14%)